|
C14ORF101 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.223800E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.736400E-03 |
| Normal-vs-Stage2 |
1.017240E-01 |
| Normal-vs-Stage3 |
2.202700E-03 |
| Normal-vs-Stage4 |
1.982310E-02 |
| Stage1-vs-Stage2 |
5.742800E-01 |
| Stage1-vs-Stage3 |
4.335000E-01 |
| Stage1-vs-Stage4 |
6.566600E-01 |
| Stage2-vs-Stage3 |
2.942200E-01 |
| Stage2-vs-Stage4 |
4.462600E-01 |
| Stage3-vs-Stage4 |
9.471800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.301400E-03 |
| Normal-vs-AfricanAmerican |
3.719900E-02 |
| Normal-vs-Asian |
4.889800E-02 |
| Caucasian-vs-AfricanAmerican |
4.841400E-01 |
| Caucasian-vs-Asian |
5.985200E-01 |
| AfricanAmerican-vs-Asian |
3.947000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.639550E-03 |
| Normal-vs-Female |
7.114300E-02 |
| Male-vs-Female |
2.999000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.815300E-03 |
| Normal-vs-Extreme_Weight |
8.998300E-03 |
| Normal-vs-Obese |
4.474000E-02 |
| Normal-vs-Extreme_Obese |
2.462300E-02 |
| Normal_Weight-vs-Extreme_Weight |
9.848600E-01 |
| Normal_Weight-vs-Obese |
2.847400E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.286200E-01 |
| Extreme_Weight-vs-Obese |
2.684000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.473200E-01 |
| Obese-vs-Extreme_Obese |
3.106600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.913000E-01 |
| Normal-vs-Age(41-60Yrs) |
8.924100E-02 |
| Normal-vs-Age(61-80Yrs) |
7.378700E-04 |
| Normal-vs-Age(81-100Yrs) |
2.760100E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.913800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.778000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.361300E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.175800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.235650E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.168200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.881800E-02 |
| Normal-VS-Type2 PRCC |
1.12539999541639E-08 |
| Normal-VS-KIRP CIMP |
3.540400E-01 |
| Normal-VS-Unclassified PRCC |
1.598380E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.22650001266322E-10 |
| Type1 PRCC-VS-KIRP CIMP |
9.131400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.137640E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.184580E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.504500E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.081000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.55559999999566E-05 |
| Normal-vs-N1 |
3.100000E-01 |
| Normal-vs-N2 |
1.062390E-03 |
| N0-vs-N1 |
1.374380E-02 |
| N0-vs-N2 |
6.748100E-02 |
| N1-vs-N2 |
3.68080000000548E-05 |
|
|
